Careers at Guided Therapeutics

HomeLuVivaPipelinePublicationsInvestorsNewsContactE-mail

How it works

Technical papers

Patents

Biophotonics

News Room

Click on Images to Download

 

  Guided Therapeutics News
 

Guided Therapeutics Announces Private Placement of up to $3,000,000 in Senior Convertible Notes

Guided Therapeutics Receives May 8th Meeting Date from FDA to Discuss LuViva® Advanced Cervical Scan PMA Application

Guided Therapeutics’ LuViva® Honored as Finalist in the Medical Device Excellence Awards

Guided Therapeutics Submits Request for Face to Face Meeting with FDA; Receives Notification on PMA Extension for LuViva® Advanced Cervical Scan

Guided Therapeutics Reports Fourth Quarter and 2013 Results

HPV Screening Beneficial for Guided Therapeutics’ LuViva® Advanced Cervical Scan in Developed Countries; No Anticipated Impact in Developing Countries

Guided Therapeutics to Report Fourth Quarter 2013 Results and Hold Conference Call

New Clinical Study Results of Guided Therapeutics’ LuViva® Advanced Cervical Scan to be Presented by Key Opinion Leaders at Top International Medical Conference

Guided Therapeutics Names Gene Cartwright as Chief Executive Officer

Guided Therapeutics Reports Third Quarter 2013 Results

Guided Therapeutics Receives $250,000 Milestone Payment

Guided Therapeutics Announces Warrant Exchange Offer

Guided Therapeutics Secures Additional Distribution for LuViva® Advanced Cervical Scan

Guided Therapeutics Receives Additional Questions from FDA for LuViva® Advanced Cervical Scan

Guided Therapeutics Reports Second Quarter 2013 Results

Guided Therapeutics Continues to Await Update from FDA on its PMA Application for LuViva® Advanced Cervical Scan

Guided Therapeutics and I.T.E.M. Medical Technologies Group Announce Turkish Ministry of Health Sponsored Cervical Cancer Prevention Program Involving the LuViva® Advanced Cervical Scan

Guided Therapeutics’ LuViva® Advanced Cervical Scan Cited as Promising Solution to Reduce Unnecessary, Painful and Costly Procedures in European Healthcare Settings

Guided Therapeutics Announces Private Placement of Convertible Preferred Stock and Warrants

Guided Therapeutics Reports First Quarter 2013 Results

Guided Therapeutics’ LuViva® Advanced Cervical Scan Clinical Trial Results to be Published in Journal, Gynecologic Oncology

Guided Therapeutics Ships Initial Edition 3 CE Marked LuViva® Advanced Cervical Scan

Guided Therapeutics Reports Year End and Fourth Quarter 2012 Results

Guided Therapeutics Receives $1.65 million from Exercised Warrants

Guided Therapeutics Passes Annual ISO Quality Audit Necessary for Continued CE Mark Certification

Guided Therapeutics to Develop Esophageal Cancer Product; Acquires Intellectual Property Rights from Konica Minolta

Guided Therapeutics Successfully Completes Canadian Standard Association Requirements for LuViva® Advanced Cervical Scan

Guided Therapeutics Successfully Completes Electrical Testing of LuViva® Advanced Cervical Scan for Edition 3 CE and Canadian Standards Association Marks

Guided Therapeutics Reports Third Quarter 2012 Results

Guided Therapeutics Submits PMA Amendment to FDA for LuViva® Advanced Cervical Scan

Guided Therapeutics to Showcase LuViva® Advanced Cervical Scan at Medica 2012

Guided Therapeutics Selects I.T.E.M. Medical Technologies Group to Distribute LuViva® Advanced Cervical Scan in Turkey and Select Territories

Guided Therapeutics Receives Initial $2.9 million from Warrant Exchange Offer

Guided Therapeutics Reports Second Quarter 2012 Results

Guided Therapeutics and FDA Agree on Plan for LuViva® Advanced Cervical Scan PMA

Guided Therapeutics Notified of CE Mark Approval for LuViva® Advanced Cervical Scan

Guided Therapeutics Announces Completion of Warrant Exchange Offer

Guided Therapeutics Announces Extension of Warrant Exchange Offer

Guided Therapeutics Extends Barrett’s Esophagus Product Development Licensing Agreement with Konica Minolta Technology Center, Inc. for Third Year

Guided Therapeutics Announces Canadian Debut of LuViva® Advanced Cervical Scan and Orders to Support Canadian Launch

Guided Therapeutics Announces Warrant Exchange Offer

Guided Therapeutics Announces Warrant Exchange Offer

Guided Therapeutics Reports First Quarter 2012 Results

Guided Therapeutics Submits Response to FDA for LuViva® Advanced Cervical Scan PMA

Guided Therapeutics’ LuViva® Advanced Cervical Scan Combined with HPV Testing Could Optimize Cervical Cancer Detection; Reduce Overtreatment of False Positives by Approximately 33%

Guided Therapeutics Appoints Linda Rosenstock, M.D., M.P.H. to its Board of Directors

   

 

 
   
   
   
   
   
   
   
   
   
   
   

 

 

 

 


©2014 Guided Therapeutics, Inc.

5835 Peachtree Corners East

Suite D

Norcross, GA 30092

770-242-8723

770-242-8639 - Fax

www.guidedinc.com

info@guidedinc.com

Terms of Service